Chronic Treatment with Mood-Stabilizers Attenuates Abnormal Hyperlocomotion of GluA1-Subunit Deficient Mice

Open Access

Peer-reviewed

Research Article

Milica Maksimovic,

Affiliation Institute of Biomedicine, Pharmacology, University of Helsinki, Helsinki, Finland
⨯
Olga Y. Vekovischeva,

Affiliation Institute of Biomedicine, Pharmacology, University of Helsinki, Helsinki, Finland
⨯
Teemu Aitta-aho,

Affiliation Institute of Biomedicine, Pharmacology, University of Helsinki, Helsinki, Finland
⨯
Esa R. Korpi

* E-mail: esa.korpi@helsinki.fi

Affiliations Institute of Biomedicine, Pharmacology, University of Helsinki, Helsinki, Finland, Department of Pharmacology, Yong Loo Lin School of Medicine, National University Health System, Singapore, Neurobiology and Ageing Programme, Life Sciences Institute, National University of Singapore, Singapore, SINAPSE, Singapore Institute for Neurotechnology, Singapore
⨯

Reader Comments (0)

Mice
Is the Subject Area "Mice" applicable to this article?

Thanks for your feedback.
Animal behavior
Is the Subject Area "Animal behavior" applicable to this article?

Thanks for your feedback.
Lithium
Is the Subject Area "Lithium" applicable to this article?

Thanks for your feedback.
Biological locomotion
Is the Subject Area "Biological locomotion" applicable to this article?

Thanks for your feedback.
Sucrose
Is the Subject Area "Sucrose" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Running
Is the Subject Area "Running" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.